|
Volumn 29, Issue 1, 1996, Pages 115-117
|
Innovative combination clinical trial designs/patient compliance: A community perspective
a |
Author keywords
Clinical trials; Combination therapies; Screening protocol
|
Indexed keywords
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIVIRUS AGENT;
CD4 ANTIGEN;
DIDANOSINE;
INDINAVIR;
INTERLEUKIN 2;
LAMIVUDINE;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
ZALCITABINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
CONFERENCE PAPER;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
T LYMPHOCYTE;
|
EID: 0029983069
PISSN: 01663542
EISSN: None
Source Type: Journal
DOI: 10.1016/0166-3542(95)00932-9 Document Type: Conference Paper |
Times cited : (2)
|
References (0)
|